Advancing New Hope for Fibrotic Disease featuring Gian Luca Araldi

In this episode of The Connect Current, host James Zanewicz sits down with Gian Luca Araldi, PhD, PharmD, MBA, PMP and Founder/CEO of Avanti Biosciences, to explore the challenge of developing new therapies for fibrotic diseases and what it takes to advance promising science toward the clinic. Gian Luca shares how Avanti Biosciences is developing novel small-molecule therapies for conditions like idiopathic pulmonary fibrosis, an area of significant unmet medical need. The conversation explores the long path from discovery to clinical development, the role of regulatory milestones and non-dilutive funding, and why translating scientific insight into patient impact requires both innovation and disciplined execution. As one of Connect's 2026 Cool Companies, Avanti represents the next generation of San Diego life sciences companies working to turn breakthrough research into meaningful therapeutic opportunities. This episode offers a look at the intersection of biotech innovation, drug development, and the future of precision medicine.